MORGAN STANLEY PLC/CALL/CVS HEALTH/88/0.1/20.12.24 Stock

Warrant

DE000MB33T60

Market Closed - Börse Stuttgart 14:33:56 2024-07-03 EDT
0.035 EUR -14.63% Intraday chart for MORGAN STANLEY PLC/CALL/CVS HEALTH/88/0.1/20.12.24
Current month-18.60%
1 month-25.53%
Date Price Change
24-07-03 0.035 -14.63%
24-07-02 0.041 -2.38%
24-07-01 0.042 -2.33%
24-06-28 0.043 +4.88%
24-06-27 0.041 -10.87%

Delayed Quote Börse Stuttgart

Last update July 03, 2024 at 02:33 pm

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying CVS HEALTH CORPORATION
Issuer Morgan Stanley
WKN MB33T6
ISINDE000MB33T60
Date issued 2023-02-01
Strike 88 $
Maturity 2024-12-20 (170 Days)
Parity 10 : 1
Emission price 1.35
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 1.43
Lowest since issue 0.022
Delta0.07x
Omega 9.253
Premium55.93x
Gearing136.61x
Moneyness 0.6443
Difference Strike 31.3 $
Difference Strike %+35.57%
Spread 0.007
Spread %16.67%
Theoretical value 0.0385
Implied Volatility 39.62 %
Total Loss Probability 96.03 %
Intrinsic value 0.000000
Present value 0.0385
Break even 88.42 €
Theta-0x
Vega0x
Rho0x

Company Profile

CVS Health Corporation is one of the leading American suppliers of health products and services. Net sales (including intragroup) break down by activity as follows: - medical insurance plan management services (45.6%; Pharmacy Benefit Management): administrative management (reimbursement management, patient claim processing, etc.), drug distribution, decision-making information, sales of medical information management services, etc.; - retail distribution (28.5%): sale of prescription pharmaceutical products, OTC products, beauty and cosmetics products. At the end of 2023, products are marketed primarily via a network of more than 9,000 outlets and via the Internet. In addition, the group offers healthcare services through more than 1,000 clinics (MinuteClinic®); - medical benefits management (25.8%); - other (0.1%).
Sector
-
More about the company

Ratings for CVS Health Corporation

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: CVS Health Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
56.7 USD
Average target price
69.1 USD
Spread / Average Target
+21.86%
Consensus